Neuphoria Therapeutics
Price & Volume
Stats
See more52W Range | $3.19-$21.40 |
Market Cap | $20.9M |
Shares Short | 15,334 |
Financials
See moreRevenue (12 Mos) | -$13,267 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | -$13,267 |
Diluted EPS | -$7.90 |
News
See moreYahoo Finance • 3 days ago
The M&A Class Action Firm Encourages $hareholders To Contact Monteverde Concerning The Merger—NRIM, NEUP, SAFT, and RMAX
Yahoo Finance • last month
Neuphoria Responds to the announcement made by London-listed Scancell Holdings plc
Yahoo Finance • 8 months ago
Neuphoria Provides Facts, Exposes False Narratives in Response to Lynx1 Fictions
Yahoo Finance • 8 months ago
Neuphoria Therapeutics Inc. Sends Letter to Stockholders
About
Address | 100 Summit Drive, Burlington, MA, United States, 01803 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 7 |